Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.Sanofi ( SNY) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 1.6%. By the end of trading, Sanofi rose $0.59 (1.1%) to $51.82 on heavy volume. Throughout the day, 3,259,439 shares of Sanofi exchanged hands as compared to its average daily volume of 1,804,400 shares. The stock ranged in a price between $51.28-$51.93 after having opened the day at $51.89 as compared to the previous trading day's close of $51.23. Other companies within the Health Care sector that increased today were: Agios Pharmaceuticals ( AGIO), up 27.8%, Questcor Pharmaceuticals ( QCOR), up 18.7%, Idenix Pharmaceuticals ( IDIX), up 12.4% and Flamel Technologies ( FLML), up 8.7%.
Sanofi researches, develops, manufactures, and markets healthcare products. The company operates in three segments: Pharmaceuticals, Human Vaccines, and Animal Health. Sanofi has a market cap of $137.8 billion and is part of the drugs industry. Shares are down 4.5% year to date as of the close of trading on Friday. Currently there are 2 analysts that rate Sanofi a buy, no analysts rate it a sell, and 4 rate it a hold. TheStreet Ratings rates Sanofi as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.